Vol 5, No 18 (September 2017): Annals of Translational Medicine (Focus on "Emerging Uses of Biomarkers in Lung Cancer Management")

Editorial

PD-L1 as a biomarker in NSCLC: challenges and future directions
Matthen Mathew, Rachael A. Safyan, Catherine A. Shu

Review Article

Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer
Khinh Ranh Voong, Josephine Feliciano, Daniel Becker, Benjamin Levy
Emerging uses of biomarkers in lung cancer management: molecular mechanisms of resistance
Shirin Attarian, Numa Rahman, Balazs Halmos
Non-invasive diagnostic platforms in management of non-small cell lung cancer: opportunities and challenges
Vamsidhar Velcheti, Nathan A. Pennell
Circulating DNA in EGFR-mutated lung cancer
Aditi P. Singh, Shenduo Li, Haiying Cheng
Emerging uses of circulating tumor DNA in advanced stage nonsmall cell lung cancer
Melina Marmarelis, Jeffrey C. Thompson, Charu Aggarwal, Tracey L. Evans, VErica Carpenter, Roger B. Cohen, Corey J. Langer, Joshua Bauml